Adenomatous polyposis coli, protein kinases, protein tyrosine phosphatase: the effect of sulindac
Related Experiment Video
Updated: Aug 9, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
1Department of Surgery, University of Arizona, Tucson, USA.
Abstract:
A putative explanation of the effect of sulindac on adenomatous colon and duodenal polyps from clinical observations and related in vitro experiments is presented. In cells with mutant APC genes, persistent high prostaglandin content of polyps leads to desensitization, downregulation of adenylate cyclase, uncoupling of cAMP synthesis from prostaglandin, and inactivation of protein kinase A (PKA). It is suggested that in normal cells, (APC) protein binds to catenins and microtubules to maintain structure and contribute to cell-cell communication, adherence, and the dephosphorylated state, a necessary condition for such functions. Cells with mutant APC product become isolated, deprived of communication and adhesion to other epithelial cells, overphosphorylated, and without corrective capability. The latter is largely due to downregulation of cAMP synthesis and protein kinase A activity secondary to high prostaglandin. Three main biochemical defects ensue: (1) the restrictive influence of PKA catalyzed phosphorylation of Raf-1 kinase and resultant effects on the MAP kinase cascade and transcription is lost, (2) the transcription of immediate early genes, including cyclooxygenase is stimulated, and (3) the stimulation of protein tyrosine phosphatase (PTPase) by PKA is in abeyance. These putative abnormalities are reversed by inhibition of cyclooxygenase-1 by sulindac. cAMP synthesis and PKA activity return to normal. PKA catalyzed phosphorylations block Raf-1 kinase at the confluence of the Ras and protein kinase C pathways. The MAP kinase cascade is inhibited as is transcription of immediate early genes. At the same time PKA stimulates PTPase, which dephosphorylates the cytoskeleton and restores cell-cell communication, adherence, and structure. The transformed phenotype is circumvented by adjustment of the phosphorylation state and mutant cells rejoin the epithelial community. The redox state of cytoplasm in mutant cells may be shifted toward reduction.
Insights
Sulindac reverses defects in adenomatous polyps by inhibiting cyclooxygenase-1, restoring cell communication and normal function. This drug normalizes prostaglandin levels, cAMP synthesis, and protein kinase A activity.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Adenomatous polyps are associated with mutations in the APC gene.
- Mutant APC leads to high prostaglandin levels, desensitization of adenylate cyclase, and inactivation of protein kinase A (PKA).
- This results in cellular isolation, overphosphorylation, and loss of corrective capabilities.
Purpose of the Study:
- To present a putative explanation for sulindac's effect on adenomatous polyps.
- To elucidate the molecular mechanisms underlying polyp formation and sulindac's therapeutic action.
Main Methods:
- Clinical observations and in vitro experiments.
- Analysis of cellular signaling pathways, including cAMP synthesis, PKA activity, and MAP kinase cascade.
- Investigation of gene transcription and protein phosphorylation states.
Main Results:
- Sulindac, by inhibiting cyclooxygenase-1, reverses abnormalities caused by mutant APC.
- Restoration of normal cAMP synthesis and PKA activity.
- PKA re-establishes control over Raf-1 kinase, MAP kinase cascade, and immediate early gene transcription, while stimulating protein tyrosine phosphatase (PTPase).
Conclusions:
- Sulindac normalizes the phosphorylation state of cellular proteins.
- Restores cell-cell communication, adherence, and epithelial structure.
- Circumvents the transformed phenotype of mutant cells, potentially aiding in polyp regression.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
11:13Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase